Literature DB >> 7915998

Biotype-specific tcpA genes in Vibrio cholerae.

J R Iredell1, P A Manning.   

Abstract

The tcpA gene, encoding the structural subunit of the toxin-coregulated pilus, has been isolated from a variety of clinical isolates of Vibrio cholerae, and the nucleotide sequence determined. Strict biotype-specific conservation within both the coding and putative regulatory regions was observed, with important differences between the El Tor and classical biotypes. V. cholerae O139 Bengal strains appear to have El Tor-type tcpA genes. Environmental O1 and non-O1 isolates have sequences that bind an El Tor-specific tcpA DNA probe and that are weakly and variably amplified by tcpA-specific polymerase chain reaction primers, under conditions of reduced stringency. The data presented allow the selection of primer pairs to help distinguish between clinical and environmental isolates, and to distinguish El Tor (and Bengal) biotypes from classical biotypes of V. cholerae. While the role of TcpA in cholera vaccine preparations remains unclear, the data strongly suggest that TcpA-containing vaccines directed at O1 strains need include only the two forms of TcpA, and that such vaccines directed at (O139) Bengal strains should include the TcpA of El Tor biotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915998     DOI: 10.1111/j.1574-6968.1994.tb07074.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  17 in total

1.  Molecular characterization of a new variant of toxin-coregulated pilus protein (TcpA) in a toxigenic non-O1/Non-O139 strain of Vibrio cholerae.

Authors:  B Nandi; R K Nandy; A C Vicente; A C Ghose
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains.

Authors:  K H Thelin; R K Taylor
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.

Authors:  M K Waldor; H Tschäpe; J J Mekalanos
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

5.  Analysis of an autoregulatory loop controlling ToxT, cholera toxin, and toxin-coregulated pilus production in Vibrio cholerae.

Authors:  R R Yu; V J DiRita
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

6.  Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Francisca Cerda; Manohar John; Jason B Harris; Regina C Larocque; Firdausi Qadri; Stephen B Calderwood; Ronald K Taylor; Edward T Ryan
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Outer membrane translocation arrest of the TcpA pilin subunit in rfb mutants of Vibrio cholerae O1 strain 569B.

Authors:  J R Iredell; P A Manning
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

8.  Molecular analyses of a putative CTXphi precursor and evidence for independent acquisition of distinct CTX(phi)s by toxigenic Vibrio cholerae.

Authors:  E F Boyd; A J Heilpern; M K Waldor
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

9.  The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.

Authors:  Muhammad Asaduzzaman; Edward T Ryan; Manohar John; Long Hang; Ashraful I Khan; A S G Faruque; Ronald K Taylor; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa.

Authors:  Ashrafus Safa; Jinath Sultana; Phung Dac Cam; James C Mwansa; Richard Y C Kong
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.